Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 525 active Multiple Myeloma trials
Limited-duration Teclistamab
Study Type: Interventional Phase 2
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Study Type: Interventional
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Study Type: Interventional Phase 3
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Study Type: Interventional Phase 2
Elimination of Minimal Residual Disease After Transplant
Study Type: Interventional Phase 2
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Study Type: Observational
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
Study Type: Interventional Phase 1
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Study Type: Interventional Phase 1
There are 525 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now